SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-130728
Filing Date
2023-05-01
Accepted
2023-05-01 17:20:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d480900ddefa14a.htm DEFA14A 11147
2 GRAPHIC g480900g01p37.jpg GRAPHIC 374766
3 GRAPHIC g480900g01p38.jpg GRAPHIC 270609
  Complete submission text file 0001193125-23-130728.txt   901470
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14027 | Film No.: 23875211
SIC: 3841 Surgical & Medical Instruments & Apparatus